CLINICAL TRIALS PROFILE FOR TRICAPRILIN

Clinical Trials for tricaprilin

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00142805 ↗	Tricaprilin in Mild to Moderate Alzheimer's Disease	Completed	Accera, Inc.	Phase 2	The purpose of this study is to evaluate the safety, tolerability and effectiveness of tricaprilin administered once a day for ninety days in subjects with mild to moderate, probable Alzheimer's disease.
NCT00142805 ↗	Tricaprilin in Mild to Moderate Alzheimer's Disease	Completed	Cerecin	Phase 2	The purpose of this study is to evaluate the safety, tolerability and effectiveness of tricaprilin administered once a day for ninety days in subjects with mild to moderate, probable Alzheimer's disease.
NCT00355550 ↗	Tricaprilin In Age-Associated Memory Impairment	Completed	Accera, Inc.	Phase 2	The purpose of this study is to determine whether tricaprilin, a compound that increases energy availability in the brain, improves memory in older adults with "normal" loss of memory abilities since early adult life.
NCT00355550 ↗	Tricaprilin In Age-Associated Memory Impairment	Completed	Cerecin	Phase 2	The purpose of this study is to determine whether tricaprilin, a compound that increases energy availability in the brain, improves memory in older adults with "normal" loss of memory abilities since early adult life.
NCT03551769 ↗	Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production	Completed	Accera, Inc.	Phase 1	This is a Phase I, single center, open label, fixed-order, crossover, food-effect, pharmacokinetic (PK) study recruiting healthy, adult, male subjects.
NCT03551769 ↗	Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production	Completed	Cerecin	Phase 1	This is a Phase I, single center, open label, fixed-order, crossover, food-effect, pharmacokinetic (PK) study recruiting healthy, adult, male subjects.

Clinical Trial Conditions for tricaprilin

Condition Name

Condition Name for
Intervention	Trials
Alzheimer Disease	8
Alzheimer's Disease	2
Age-Associated Memory Impairment	1
Infantile Spasm	1

Condition MeSH

Condition MeSH for
Intervention	Trials
Alzheimer Disease	10
Migraine Disorders	1
Memory Disorders	1
Spasms, Infantile	1

Clinical Trial Locations for tricaprilin

Trials by Country

Trials by Country for
Location	Trials
United States	11
Australia	7
Singapore	1

Trials by US State

Trials by US State for
Location	Trials
Florida	3
Arizona	2
Massachusetts	1
Texas	1
Oregon	1

Clinical Trial Progress for tricaprilin

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase	Trials
Phase 3	2
Phase 2	3
Phase 1	9

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase	Trials
Completed	6
Not yet recruiting	4
Recruiting	2

Clinical Trial Sponsors for tricaprilin

Sponsor Name

Sponsor Name for
Sponsor	Trials
Cerecin	14
Accera, Inc.	5

Sponsor Type

Sponsor Type for
Sponsor	Trials
Industry	19